Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - 3 days ago FDA Panel Endorses Donanemab to Treat Early-Stage Alzheimer Disease - 6 months ago
2	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Alzheimer's Data Withdrawn - 12 days ago Novel Agent Reduces Monthly Migraine Days - 3 months ago Why Alzheimer's Drug Approval Delay? $3 Billion in DMD Gene Therapy; ADHD Prevalence - 8 months ago Opening Blood-Brain Barrier to Deliver Alzheimer's Drug Shows Promise - 11 months ago Alzheimer's Vaccines Are Back; Streamlining Prior Authorization; Rare APOE Variant - about 1 year ago Subcutaneous Alzheimer's Drug May Be on the Horizon - about 1 year ago
3	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Inebilizumab for Myasthenia Gravis Reduces Steroid Burden - 18 days ago Sequencing in Advanced Urothelial Carcinoma - 23 days ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 5 months ago Dupilumab Reduces Airway Inflammation, Mucus Plugs in Asthma Patients - 8 months ago Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer - 11 months ago Adding Tucatinib to T-DM1 Shows PFS Benefit in HER2-Positive Breast Cancer - 11 months ago 'Exploding' Field of Antibody-Drug Conjugates Makes Inroads in Ovarian Cancer - 12 months ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - 12 months ago Tralokinumab Controls Moderate-to-Severe AD Over the Long Term - 12 months ago IL-13 Blocker for Eczema Maintains Efficacy at Less-Frequent Dosing - about 1 year ago The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer - about 1 year ago
4	Kristen Monaco MedPage Today	Complement Inhibitor Shows Promise for Rare Kidney Disorder - 27 days ago Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - 4 months ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Another Win for Antibody-Drug Conjugate in HER2+ Breast Cancer With Brain Mets - 2 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 2 months ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - 12 months ago First Treatment Approved for Genetic Clotting Disorder - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago
6	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Lebrikizumab Wins FDA Approval for Eczema - 2 months ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 2 months ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 5 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - 8 months ago FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications - 9 months ago Results Show Dupilumab Reduces Airway Inflammation In Asthma - 9 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 9 months ago FDA Approves Adalimumab-ryvk as Interchangeable Biosimilar for Humira - 9 months ago Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months - 10 months ago Biogen Reprioritizes Alzheimer Disease Franchise, Discontinuing Aducanumab and Advancing Lecanemab - 10 months ago Study: Biosimilarities Found Between Yusimry and Humira for Immune, Rheumatic Conditions - 11 months ago FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - 11 months ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - about 1 year ago Subcutaneous Lecanemab Demonstrates Greater Amyloid Plaque Removal Than Intravenous Lecanemab - about 1 year ago
8	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	AstraZeneca, Daiichi Sankyo Drug Enhertu Becomes First Tumor-Agnostic ADC Cancer Med - 8 months ago
9	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	Upadacitinib Can Significantly Improve Clinical Outcomes in Patients With Atopic Dermatitis - 9 months ago FDA Questions Donanemab Efficacy for the Treatment of Alzheimer Disease - 9 months ago FDA Accepts BLA for Datopotamab Deruxtecan for the Treatment of NSCLC - 9 months ago
10	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare	FDA Fast Tracks Candel Therapeutics' Novel Treatment for Pancreatic Ductal Adenocarcinoma - 11 months ago FDA Accepts Biologics License Application for CSL Behring’s Garadacimab for Hereditary Angioedema - 11 months ago FDA Approves Expanded Indication for LEO Pharma's Adbry for Pediatric Patients With Atopic Dermatitis - 11 months ago FDA Accepts sBLA for Interchangeability Designation for Latest Humira Biosimilar - about 1 year ago FDA Approves Takeda's Treatment for Rare Blood Clotting Disorder - about 1 year ago FDA Approves Cosentyx as Treatment Option for Hidradenitis Suppurativa - about 1 year ago

Journalists covering aducanumab